Lakhmir Chawla, M.D. | Chief Medical Officer
Dr. Chawla has served as our Chief Medical Officer since July 2015. From 2014 to 2015, he served as Chief of the Division of Intensive Care Medicine at the Washington D.C. Veterans Affairs Medical Center. From 2002 to 2014, Dr. Chawla was on faculty at the George Washington University and achieved the rank of Professor of Medicine. Dr. Chawla received a B.A. degree in medical science from Boston University and an M.D. degree from Rutgers New Jersey Medical School.
Stew Kroll | Chief Development Officer
Mr. Kroll has served as our Chief Development Officer since December 2019 and previously as Senior Vice President of Biometrics, from 2017 to 2019. From 2005 to 2016, he held various positions at Threshold Pharmaceuticals, Inc., most recently serving as Chief Operating Officer. From 2000 to 2005, Mr. Kroll served as Senior Director of Biostatistics at Corixa Corporation. From 1997 to 2000, he held various positions at Coulter Pharmaceutical, Inc., most recently serving as Director of Biostatistics. Mr. Kroll received an M.A. degree and B.A. degree in statistics from the University of California, Berkeley.
Dennis Mulroy | Chief Financial Officer
Mr. Mulroy has served as our Chief Financial Officer since April 2015. From 2005 to 2015, he served as Chief Financial Officer of Taxus Cardium Pharmaceuticals Group, Inc. From 2004 to 2005, Mr. Mulroy served as Chief Financial Officer of Molecular Imaging, Inc. From 2001 to 2003, he served as Chief Financial Officer of SeraCare Life Sciences, Inc. Mr. Mulroy began his career at Ernst & Young LLP. Mr. Mulroy received a B.S. degree in business administration, with an emphasis in accounting, from the University of San Diego and is a Certified Public Accountant (inactive) in the state of California.
James Rolke | Chief Scientific Officer
Mr. Rolke has served as our Chief Scientific Officer since January 2017 and previously held various positions, most recently serving as Vice President of Research & Development, from 2012 to 2017. From 2009 to 2012, he served as Chief Technology Officer at Pluromed, Inc. (acquired by Sanofi). From 2007 to 2009, Mr. Rolke served as Director of Operations at Prospect Therapeutics, Inc. From 2006 to 2007, he served as Associate Director of Pharmaceutical Development at Mersana Therapeutics, Inc. From 2003 to 2006, Mr. Rolke served as Manager of Process Development at GlycoGenesys, Inc. Mr. Rolke received a B.S. degree in chemistry from Keene State College.
Darryl Wellinghoff | Chief Commercial Officer
Mr. Wellinghoff has served as our Chief Commercial Officer since March 2019. From 2016 to 2018, he served as the Executive Vice President at Mainstreet Health. From 2001 to 2016, Mr. Wellinghoff held various positions at The Medicines Company, most recently serving as Senior Vice President, Americas. From 1997 to 2001, he held various commercial positions at Bristol-Myers Squibb. Mr. Wellinghoff received a B.A. degree in English from Florida State University.